BioCentury
ARTICLE | Company News

Alkermes, Genentech deal

April 19, 1999 7:00 AM UTC

The companies expanded their 1995 collaboration on Nutropin Depot injectable sustained release formulation of GNE's human growth hormone that uses ALKS' ProLease drug delivery system. As expanded, the companies, which have focused on pediatric growth hormone deficiency, will add a new indication as well as process and formulation development and manufacturing activities. ...